Indication
Treatment of juvenile idiopathic arthritis, paediatric plaque psoriasis, paediatric uveitis
Loading your page…
Loading your page…
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Psoriasis;Arthritis, Psoriatic;Spondylitis, Ankylosing;Uveitis
Marketing Authorisation Holder: Pfizer Europe MA EEIG
INN: adalimumab
AI Drug & Interaction Analysis
Free account required
Ask Osler about Fyzoclad: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.